Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats
- PMID: 27916218
- DOI: 10.1016/j.amjms.2016.09.008
Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats
Abstract
Background: Malignant hypertension is a life-threatening condition, and its pathophysiology is still poorly understood. The present study was designed to evaluate the role of interaction of the renin-angiotensin system with 20-hydroxyeicosatetraenoic acid (20-HETE), a product of cytochrome P450 (CYP)-dependent ω-hydroxylase pathway, in the pathophysiology of angiotensin II (ANG II)-dependent malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Methods: Malignant hypertension was induced by 12 days׳ dietary administration of 0.3 % indole-3-carbinol (I3C), a natural xenobiotic that activates a mouse renin gene. We hypothesized that chronic administration of fenofibrate, 190mg/kg body weight, a lipid-lowering drug, should increase renal production of 20-HETE, a tubular transport inhibitor; an expected increase in sodium excretion would oppose the development of ANG II-dependent malignant hypertension. Blood pressure was monitored by radiotelemetry, and at the end of the experiment rats were prepared for renal functional studies to evaluate in vivo the pressure-natriuresis relationship in response to stepwise reductions in renal arterial pressure (RAP).
Results: In I3C-induced rats, the treatment with fenofibrate significantly attenuated hypertension and improved the slope of the pressure-natriuresis relationship. Although fenofibrate treatment increased kidney gene and protein expression of CYP4A1, a major isoform responsible for 20-HETE formation, it did not increase renal 20-HETE concentration. On the contrary, fenofibrate treatment significantly suppressed renin gene expression, plasma renin activity and plasma and kidney ANG II levels.
Conclusions: Fenofibrate treatment significantly attenuated the course of malignant hypertension in I3C-induced CYP1a1-Ren-2 transgenic rats, and the mechanism responsible for antihypertensive action was fenofibrate-induced suppression of renin-angiotensin system activity.
Keywords: 20-hydroxyeicosatetraenoic acid; Cytochrome P450 metabolites; Malignant hypertension; Renin-angiotensin system.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.Biosci Rep. 2018 Sep 12;38(5):BSR20171496. doi: 10.1042/BSR20171496. Print 2018 Oct 31. Biosci Rep. 2018. PMID: 30054426 Free PMC article.
-
Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.J Hypertens. 2009 Mar;27(3):575-86. doi: 10.1097/hjh.0b013e32831cbd5a. J Hypertens. 2009. PMID: 19330918
-
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.Clin Exp Pharmacol Physiol. 2016 Apr;43(4):438-49. doi: 10.1111/1440-1681.12553. Clin Exp Pharmacol Physiol. 2016. PMID: 26833491
-
Renal mechanisms of angiotensin II-induced hypertension.Semin Nephrol. 2000 Sep;20(5):417-25. Semin Nephrol. 2000. PMID: 11022893 Review.
-
The role of 20-HETE in androgen-mediated hypertension.Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):45-53. doi: 10.1016/j.prostaglandins.2011.06.006. Epub 2011 Jun 22. Prostaglandins Other Lipid Mediat. 2011. PMID: 21722750 Free PMC article. Review.
Cited by
-
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.Biosci Rep. 2018 Sep 12;38(5):BSR20171496. doi: 10.1042/BSR20171496. Print 2018 Oct 31. Biosci Rep. 2018. PMID: 30054426 Free PMC article.
-
Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.Front Pharmacol. 2019 Jan 23;10:18. doi: 10.3389/fphar.2019.00018. eCollection 2019. Front Pharmacol. 2019. PMID: 30728778 Free PMC article.
-
Bilirubin, a Cardiometabolic Signaling Molecule.Hypertension. 2018 Oct;72(4):788-795. doi: 10.1161/HYPERTENSIONAHA.118.11130. Hypertension. 2018. PMID: 30354722 Free PMC article. Review. No abstract available.
-
Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.Kidney Blood Press Res. 2018;43(2):329-349. doi: 10.1159/000487902. Epub 2018 Mar 6. Kidney Blood Press Res. 2018. PMID: 29529602 Free PMC article.
-
Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.J Am Soc Nephrol. 2017 Oct;28(10):2845-2855. doi: 10.1681/ASN.2017030252. Epub 2017 Jul 12. J Am Soc Nephrol. 2017. PMID: 28701518 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous